난치성 이루를 동반한 만성 호산구성 중이염 1예
A Case of Eosinophillic Otitis Media with Intractable Otorrhea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Eosinophilic otitis media (EOM) is a newly recognized intractable middle ear disease, characterised by the accumulation of eosinophils in middle ear effusion and middle ear mucosa. Since EOM patients show gradual or sudden deterioration of hearing, it is important to properly diagnose EOM and to start adequate treatment for EOM. We experienced a case of EOM, so discuss the clinical features, pathogenesis, and management of EOM. EOM is often complicated by rhinosinusitis (eosinophilic sinusitis). High-tone loss is more frequently found and more severe in EOM patients than in chronic otitis media control patients, and EOM patients sometimes become deaf suddenly. Systemic or topical steroid administration is the most effective treatment for patients with EOM. The instillation of prednisolone, a suspension of steroids, into the middle ear is very effective for controlling eosinophilic inflammation in our case. It is very important to explain to patients with EOM that the disease may last for a long period and that progressive and sudden hearing loss may occur.
Abstract
Eosinophilic otitis media (EOM) is a newly recognized intractable middle ear disease, characterised by the accumulation of eosinophils in middle ear effusion and middle ear mucosa. Since EOM patients show gradual or sudden deterioration of hearing, it is important to properly diagnose EOM and to start adequate treatment for EOM. We experienced a case of EOM, so discuss the clinical features, pathogenesis, and management of EOM. EOM is often complicated by rhinosinusitis (eosinophilic sinusitis). High-tone loss is more frequently found and more severe in EOM patients than in chronic otitis media control patients, and EOM patients sometimes become deaf suddenly. Systemic or topical steroid administration is the most effective treatment for patients with EOM. The instillation of prednisolone, a suspension of steroids, into the middle ear is very effective for controlling eosinophilic inflammation in our case. It is very important to explain to patients with EOM that the disease may last for a long period and that progressive and sudden hearing loss may occur.
참고문헌 (11)
- Iino Y, "Eosinophilic otitis media: a new middle ear disease entity", Current Allergy Asthma Rep, 8(6), pp.525~530 (2008)
- Nakagawa T, "Intractable Otitis Media with Eosinophils: importance of diagnosis and validity of treatment for hearing preservation", ORL J Otorhinolaryngol Relat Spec, 68(2), pp.118~122 (2006)
- Mogi G, "The role of IgE-mediated immunity in otitis media: fact or fiction", Ann N Y Acad Sci, 830, pp.61~69 (1997)
- Iino Y, "Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma", Clin Exp Allergy, 31(7), pp.1135~1143 (2001)
- Shiro Kanegasaki, "Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media", Clinical and Experimental Allergy, 35(10), pp.1370~1376, Blackwell Publishing
- Iino Y, "Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry", Arch Otolaryngol Head Neck Surg, 132(10), pp.1109~1114 (2006)
- Nagamine H, "Clinical characteristics of so called eosinophilic otitis media", Auris Nasus Larynx, 29(1), pp.19~28 (2002)
- Iino Y, "Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media", Otol Neurotol, 31(1), pp.100~104 (2010)
- Schwartz RH, "Use of a short course of prednisone for treating middle ear effusion. A double-blind crossover study", Ann Otol Rhinol Laryngol Suppl, 89, pp.296~300 (1980)
- Kubo M, "Intratympanic application of hydrocortisone for the treatment of otitis media with effusion", Pract Otol, 54, pp.456~458 (1961)
- Wada T, "Successful treatment of eosinophilic otitis media using ramatroban: report of two cases", Auris Nasus Larynx, 33(4), pp.455~460 (2006)